Tus kws kho mob
QP15-16 Zenith American Solutions 835 Electronic Remittance A dvice
Hnub Tim pib siv tau lub khoos kas: Lub Xya Hli Ntuj Tim 07, 2016
Tshawb Nrhiav
Nthuav pom cov txiaj ntsig tshwm sim 3041 - 3050 ntawm 4179
Tus kws kho mob
QP9-16 PCCs Will No Longer Be Listed on (MHCP) Subscriber ID Cards
Hnub Tim pib siv tau lub khoos kas: Lub Plaub Hlis Ntuj Tim 07, 2016
Tus kws kho mob
QP92-24 Process Update for Post-Acute Care Authorizations managed by eviCore Healthcare
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Ob Hlis Ntuj Tim 23, 2024
Tus kws kho mob
QP91-24 Commercial Pharmacy Benefit Update: New and Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective February 1, 2025
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Ob Hlis Ntuj Tim 23, 2024
Tus kws kho mob
QP90-24 MHCP Pharmacy Benefit Update: New and Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective January 1, 2025
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Ob Hlis Ntuj Tim 23, 2024
Tus kws kho mob
QP93-24 Blue Cross and Blue Shield of Minnesota Collaborating with Maven
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Ob Hlis Ntuj Tim 23, 2024
Tus kws kho mob
QP94-24 MHCP Pharmacy Benefit Exclusion for Darzalex Faspro®, Supprelin® LA and Visudyne®
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Ob Hlis Ntuj Tim 23, 2024
Tus kws kho mob
QP96-24 Prescription Drug Electronic Prior Authorization (ePA) Submission Process Update
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Ob Hlis Ntuj Tim 23, 2024
Tus kws kho mob
QP97-24 Commercial Pharmacy Benefit Exclusion for oxytocin, Pitocin® and Prepidil® Gel
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Ob Hlis Ntuj Tim 23, 2024
Tus kws kho mob
QP95-24 Commercial Pharmacy Benefit Exclusion for lanreotide, Ultomiris® and Visudyne®
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Ob Hlis Ntuj Tim 23, 2024